- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05365334
Skeletal Muscle and Adipose Tissue Responses After Acute Exercise: Comparing Effects of Three Different Intensities (3X)
July 25, 2024 updated by: Jeffrey F Horowitz, University of Michigan
The study will assess the exercise-induced changes in chromatin accessibility and gene expression in a cell type-specific manner in skeletal muscle from healthy adults in response to exercise at three different intensities - 1) low-intensity continuous exercise, 2) moderate-intensity continuous exercise, and 3) high-intensity interval exercise.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age:18-40
- Body Mass Index: 20-30 kg/m2
- Must engage in regularly planned aerobic-type exercise at moderate-vigorous intensity, 3 times per week for at least 30-60 minutes/session
- Women must have regularly occurring menses and must be premenopausal
- Subject willingness to opt-in for the Michigan Genomics Initiative (MGI) Repository
Exclusion Criteria:
- Evidence/history of cardiovascular or metabolic disease.
- Taking anti-coagulate medications or medications known to affect metabolism or inflammation
- Weight instability ≥ ±3kg in the last 6 months
- Tobacco or e-cigarette users
- Women must not be pregnant or actively lactating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: low-intensity continuous exercise
subjects will exercise at 30% maximal oxygen consumption (VO2max) for 45-60 minutes
|
subjects will exercise at 30% maximal oxygen consumption (VO2max) for 45-60 minutes
|
|
Experimental: moderate-intensity continuous exercise
subjects will exercise at 65% maximal oxygen consumption (VO2max) for 30-45 minutes
|
subjects will exercise at 65% maximal oxygen consumption (VO2max) for 30-45 minutes
|
|
Experimental: high-intensity interval exercise
subjects will completed 10x1minute exercise intervals at maximal oxygen consumption (VO2max) with 1 minute active recovery between
|
subjects will completed 10x1minute exercise intervals at maximal oxygen consumption (VO2max) with 1 minute active recovery between
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
post-translational modifications of skeletal muscle oxidative enzymes
Time Frame: 30 minutes before exercise
|
Western blot
|
30 minutes before exercise
|
|
post-translational modifications of skeletal muscle oxidative enzymes
Time Frame: immediately after exercise
|
Western blot
|
immediately after exercise
|
|
post-translational modifications of skeletal muscle oxidative enzymes
Time Frame: 60 minutes after exercise
|
Western blot
|
60 minutes after exercise
|
|
post-translational modifications of Adipose tissue metabolic proteins
Time Frame: 15 minutes before exercise
|
Western blot
|
15 minutes before exercise
|
|
post-translational modifications of Adipose tissue metabolic proteins
Time Frame: 75 minutes after exercise
|
Western blot
|
75 minutes after exercise
|
|
mRNA expression of skeletal muscle oxidative enzymes
Time Frame: 30 minutes before exercise
|
qPCR
|
30 minutes before exercise
|
|
mRNA expression of skeletal muscle oxidative enzymes
Time Frame: immediately after exercise
|
qPCR
|
immediately after exercise
|
|
mRNA expression of skeletal muscle oxidative enzymes
Time Frame: 60 minutes after exercise
|
qPCR
|
60 minutes after exercise
|
|
mRNA expression of adipose tissue metabolic enzymes
Time Frame: 15 minutes before exercise
|
qPCR
|
15 minutes before exercise
|
|
mRNA expression of adipose tissue metabolic enzymes
Time Frame: 75 minutes after exercise
|
qPCR
|
75 minutes after exercise
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 13, 2021
Primary Completion (Actual)
June 23, 2023
Study Completion (Actual)
June 23, 2023
Study Registration Dates
First Submitted
April 8, 2022
First Submitted That Met QC Criteria
May 3, 2022
First Posted (Actual)
May 9, 2022
Study Record Updates
Last Update Posted (Actual)
July 26, 2024
Last Update Submitted That Met QC Criteria
July 25, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- HUM00204857
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low intensity exercise session
-
University of PoitiersCompletedMenopause | Blood Pressure | Cognitive DeclineFrance
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamNot yet recruitingAging | Cognitive Decline | Neuroplasticity | Stroke, Chronic | Motor DysfunctionUnited States
-
Robert Ross, PhDRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
Christal L BadourNational Institute of Mental Health (NIMH); University of Texas at AustinRecruiting
-
Yale UniversityNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
Universidade Federal do CearaCompletedDiabetes MellitusBrazil
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
-
Kessler FoundationNational Cancer Institute (NCI); Kessler Institute for RehabilitationCompletedBreast CancerUnited States